| 0.01% Hypochlorous Acid in the Treatment of Blepharitis (NCT05608980) | Eye & ENT Hospital of Fudan University | 2022-07-01 |
| Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye (NCT05062564) | Azienda Ospedaliero-Universitaria Careggi | 2021-09-07 |
| Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (NCT04784091) | Tarsus Pharmaceuticals, Inc. | 2021-04-29 |
| Analysis of the Results of Intense Pulsed Light Treatment Previously to Laser Refractive Surgery (NCT05139511) | Vissum, Instituto Oftalmológico de Alicante | 2021-02-15 |
| Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis (NCT04675242) | Nicox Ophthalmics, Inc. | 2020-12-14 |
| Evaluation of SUMMIT BRUSH in Treatment of Blepharitis (NCT04603222) | University of Notre Dame | 2020-07-21 |
| Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis (NCT03926026) | Nicox Ophthalmics, Inc. | 2019-03-18 |
| Corneal Epithelial Stem Cells and Dry Eye Disease (NCT03302273) | Sloan W. Rush, MD | 2019-02-01 |
| Short-term Effects on Tear Film (Baby Shampoo vs Blephasol) (NCT04858113) | University of Plymouth | 2018-10-01 |
| DRy Eye Outcome and Prescription Study (NCT03652415) | Guy's and St Thomas' NHS Foundation Trust | 2018-08-23 |
| Antimicrobial and Clinical Efficacy of Cliradex® as Compared With I-Lid'n Lash® Hygiene in Treating Blepharitis (NCT03422146) | Ottawa Hospital Research Institute | 2017-02-19 |
| Ocular Comfort and Inflammation in Lid Hygiene Therapy (NCT02938078) | Minnesota Eye Consultants, P.A. | 2016-10-01 |
| Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa (NCT02386774) | Centre Hospitalier Universitaire de Saint Etienne | 2016-03-21 |
| Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora (NCT02455895) | NovaBay Pharmaceuticals, Inc. | 2015-05-01 |
| Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease (NCT02218489) | Kala Pharmaceuticals, Inc. | 2014-07-01 |
| Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery (NCT01808560) | TearScience, Inc. | 2013-03-01 |
| Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis (NCT01560962) | Southern California Institute for Research and Education | 2012-01-01 |
| Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis (NCT01408082) | Sun Pharmaceutical Industries Limited | 2011-10-01 |
| A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) (NCT01269658) | Merck Sharp & Dohme LLC | 2010-12-01 |
| Blephacura Versus Baby Shampoo to Treat Blepharitis (NCT01115192) | University of Cologne | 2010-05-01 |
| A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis (NCT01102244) | Alcon Research | 2010-04-01 |
| Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis (NCT01089608) | Laboratoires Thea | 2010-03-01 |
| Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis (NCT01028027) | Bausch & Lomb Incorporated | 2009-10-01 |
| Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes (NCT00796926) | Louis Tong | 2009-07-01 |
| The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) (NCT00894530) | Merck Sharp & Dohme LLC | 2009-05-01 |
| Tea Tree Oil in the Treatment of Chronic Blepharitis (NCT01073150) | Federal University of São Paulo | 2009-04-01 |
| The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period (NCT00892970) | Merck Sharp & Dohme LLC | 2009-04-01 |
| Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis (NCT01357538) | Ursapharm Arzneimittel GmbH | 2009-02-01 |
| Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis (NCT00732446) | Federal University of São Paulo | 2008-08-01 |
| Lipids of the Human Tear Film and Their Effect on Tear Stability (NCT00803452) | University of Louisville | 2008-07-01 |
| Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis (NCT00656539) | Merck Sharp & Dohme LLC | 2008-04-01 |
| Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis (NCT00629941) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis (NCT00629590) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis (NCT00629980) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Treatment of Patients With Blepharitis and Facial Rosacea (NCT00560703) | Galderma R&D | 2007-11-01 |
| Evaluation and Treatment of Patients With Corneal and External Diseases (NCT00008541) | National Eye Institute (NEI) | 2001-01-02 |